http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20040045022-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-21 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-212 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7056 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-21 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7056 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-16 |
| filingDate | 2002-09-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2004-05-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-20040045022-A |
| titleOfInvention | Method for treating hepatitis c virus infection in treatment failure patients |
| abstract | The present invention provides a method for treating a hepatitis C virus (HCV) infected individual who has failed to respond to treatment with IFN-α but not conservative interferon-α (CIFN) or after treatment with IFN-α but not CIFN. To provide. The method generally involves administering a first dosing regimen of CIFN followed by a second dosing regimen of CIFN. Ribavirin is administered by at least a second dosing regimen. |
| priorityDate | 2001-09-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 212.